# Tata Memorial Hospital: Phase 3 study closed enrollment, 1600 enrolled (Operable Breast Cancer)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | Tata Memorial Hospital |
| Sponsor type | Non-US government |
| Study | Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer |
| NCT ID | NCT01916317 |
| Phase | Phase 3 |
| Status | active not recruiting |
| Conditions | Operable Breast Cancer |
| Intervention types | drug |
| Target enrollment | 1600 |
| Site countries | India |
| Posted | 2013-08-05 |
| Planned start | 2011-12-12 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-10-02 |
| Last update posted | 2026-10-02 |

## Why this score
- Enrollment closed: data management, monitoring and closeout ahead.
- Phase 3: multi-site, larger budget.
- 1600 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT01916317). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.